latest aidsmap news

• Low CD4 cell count, but not HIV treatment, increases risk of hardening of the arteries
• Long-term HIV treatment cuts risk of hardening of coronary artery
• Next generation first-line NNRTI, rilpivirine (TMC278) potent; lowest dose better-tolerated than efavirenz at 96 weeks
• Will male circumcision protect women, ask advocates?
• Do not use HIV tests bought over the internet, warns UK medicines regulators
• `Express care` by nurses for people starting HIV treatment decreases clinic congestion, and may improve outcomes
• HSV-2 suppression with aciclovir and HIV transmission: further conflicting data from randomised studies
• Immigration and prevention: the effect of migration on risk behaviour
• Heat-stable ritonavir tablet equivalent to soft gel capsule; may be approved next year
• Uptake of second-line treatment `stagnant` in developing world